In March 2018, India’s Department of Pharmaceuticals published guidelines proposing that domestic-made components make up 25 to 50 percent of medical devices procured by the government. The 25 percent requirement would apply to medical electronics, hospital equipment, surgical instruments, and diagnostic reagents/in-vitro diagnostics. The requirement for domestic sourcing is 50 percent for medical disposables and consumables and 40 percent for implants. Lobby groups representing multinational firms said the guidelines may not be possible to implement for high-end products because India still lacks the local production ability.
